Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2018

Feb 5, 2018

29745_iss_2018-02-05_19b241fd-d8c6-49a3-8dc6-3e14c7dffb94.html

Director's Dealing

Open in viewer

Opens in your device viewer

Eli Lilly and Company Files Form 4

INDIANAPOLIS, February 5, 2018 /PRNewswire/ --

Eli Lilly and Company (NYSE / Euronext Paris / SIX: LLY) today informs its shareholders that one or more statements of changes in beneficial ownership of its officers and directors on Form 4, as required by Section 16(a) of the U.S. Securities Exchange Act of 1934, as amended, have been filed or will be filed shortly with the U.S. Securities and Exchange Commission ("SEC").

Lilly makes available free of charge on its website, its Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, reports filed pursuant to Section 16 of the U.S. Securities Exchange Act of 1934 and amendments to those reports filed with or furnished to the SEC as soon as reasonably practicable after Lilly electronically files these documents with, or furnishes them to, the SEC.  These documents are posted on Lilly's website at www.lilly.com - under "Investors." 

The SEC maintains a website that contains reports, proxy statements and other information regarding issuers that file electronically with the SEC. These materials may be obtained electronically by accessing the SEC's home page at www.sec.gov .

Copies of the above referenced information will also be made available, free of charge, upon written request to the Company's secretary at Lilly Corporate Center, Indianapolis, Indiana 46285, U.S.A.

This is a disclosure announcement from PR Newswire.